LSIS Feed - Rheumatoid Arthritis from 21.05.2012
This is the RSS news feed of one of our preset news channels on LSIS - The Life Science Infromation Service. Please visit us to find a current view of this one and many more channels via our alerting push services: http://www.lsis.com/channels/?query=45
http://www.lsis.com/goto/r45/rss
2012-05-21T11:10:24+01:00
-
text/html
http://www.sciencedaily.com
ScienceDaily
20.05.2012 | ScienceDaily: New Target to Battle Rheumatoid Arthritis
http://www.lsis.com/channels/?query=45
ScienceDaily (May 20, 2012) A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA. Rheumatoid arthritis, a systemic inflammatory autoimmune disease that can be crippling, impacts over a million adults in the United States. See Also: (…)
-
text/html
http://www.sciencedaily.com
ScienceDaily
20.05.2012 | ScienceDaily: Drug Found for Parasite That Is Major Cause of Death Worldwide
http://www.lsis.com/channels/?query=45
ScienceDaily (May 20, 2012) Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death of more than 70,000 people worldwide each year. See Also: Health & Medicine Pharmacology Personalized Medicine Diseases and Conditions Plants & Animals (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: Protective role of systemic Furin in immune response-induced-arthritis.
http://www.lsis.com/channels/?query=45
OBJECTIVES: Rheumatoid arthritis (RA) is an auto-immune joint disease associated with chronic inflammation of the synovium that causes profound damage of joints. Inflammation results in part in the influx of immune cells secreting inflammatory cytokines and the reduction in the number of regulatory T cells (T(reg) ). We assessed the impact of Furin, a protease implicated in the proteolytic activity of various precursor proteins, involved both in the regulation of protease maturation and immune (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: Vascular Function and Handgrip Strength in Rheumatoid Arthritis Patients.
http://www.lsis.com/channels/?query=45
Objective. To examine the relationship of handgrip strength with forearm blood flow (BF) and vascular resistance (VR) in rheumatoid arthritis (RA) patients. Methods. Forearm BF at rest (RBF) and after upper arm occlusion (RHBF), and handgrip strength were examined in 78 individuals (RA = 42 and controls (CT) = 36). Subsequently, VR at rest (RVR) and after occlusion (RHVR) were calculated. Results. The patients' RBF (P = 0.02) and RHBF (P = 0.0001) were less, whereas RVR (P = 0.002) and RHVR (P (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: Saccharomyces boulardii fungemia caused by treatment with a probioticum.
http://www.lsis.com/channels/?query=45
Saccharomyces cerevisiae, known as baker's yeast, is normally considered a non-pathogenic yeast. A genetically very similar subtype, S boulardii, is used in a probioticum (Sacchaflor) to prevent antibiotic-associated diarrhoea and in the treatment of recurrent Clostridium difficile associated diarrhoea. The authors present a case report of a 79-year-old woman with rheumatoid arthritis, who after a bowel resection developed S boulardii fungemia. Her postoperative course was complicated by (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: An unusual case of hyperthyroidism associated with jaundice and hypercalcaemia.
http://www.lsis.com/channels/?query=45
A 51-year-old woman with rheumatoid arthritis presented with a 3 month history of painless jaundice and significant weight loss and constipation. Laboratory values were consistent with hyperthyroidism, cholestatic jaundice and parathyroid hormone-independent hypercalcaemia. Three months after beginning of methimazole, euthyroidism was achieved and serum adjusted calcium, total and direct bilirubin levels were normal. |-| BMJ Case Rep. |-| Klangjareonchai T. |-| Department of Medicine, (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: Complication of etanercept treatment for rheumatoid arthritis - purulent pericarditis caused by a commensal organism.
http://www.lsis.com/channels/?query=45
The patient presented with increasing fatigue and dyspnoea. The patient had medical history of rheumatoid arthritis for which she had been taking methotrexate for the past 15 years and etanercept for the past 6 years. Initial diagnosis was cardiac failure but further investigation by echocardiogram revealed a large pericardial effusion. Empirical piperacillin-tazobactam was started due to moderately raised inflammatory markers. Four hundred millilitre of frank pus was aspirated from the (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: Visceral leishmaniasis in immunosuppressed Caucasian patient.
http://www.lsis.com/channels/?query=45
A 64-year-old man was admitted with fever, weight loss, fatigue and night sweats. He was known to have rheumatoid arthritis and had been taking methotrexate for 1 year. He had worked in Saudi Arabia until 1994 and had been living in Spain for 6 months every year. Clinical examination showed an enlarged spleen. Routine investigations showed pancytopaenia. Serial blood cultures were negative. CT scan confirmed splenomegaly and was otherwise unremarkable. Bone marrow biopsy revealed Leishmania (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure: Clinical Course and Outcomes.
http://www.lsis.com/channels/?query=45
PURPOSE: To characterize the spectrum and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) occurring with oral bisphosphonate therapy. MATERIALS AND METHODS: We assembled a retrospective cohort of patients who had developed oral BRONJ according to the 2009 American Association of Oral and Maxillofacial Surgeons criteria and received care within Kaiser Permanente, Northern California, during 2004 to 2011. Patients with intravenous bisphosphonate exposure were excluded. The (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: The role of Inflammation & Cardiovascular Disease Risk on Microvascular and Macrovascular Endothelial Function in Patients with Rheumatoid Arthritis: a Cross-sectional and Longitudinal Study.
http://www.lsis.com/channels/?query=45
ABSTRACT: BACKGROUND: Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease (CVD), and it has been postulated that RA disease-related inflammation contributes to endothelial dysfunction. The aim of the present work was to examine predictors (RA-related and CVD risk factors) and anti-tumour necrosis factor-alpha (anti-TNFalpha) treatment effects on endothelial function in different vascular beds. METHODS: Microvascular endothelial function (Laser Doppler (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-? Drugs.
http://www.lsis.com/channels/?query=45
OBJECTIVES: To describe rates of first significant infection of rheumatoid arthritis patients who switch between anti-tumor necrosis factor (aTNF) drugs. METHODS: Subjects with rheumatoid arthritis who received only aTNF drugs were observed in an insurance claims database from January 2001 to December 2007. Nonswitchers (NS) remained on one aTNF throughout the study period (date of the first aTNF claim was the index date); switchers (S) received at least one other aTNF (claim date for the 2nd (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Primary total knee arthroplasty using the P.F.C Sigma-rotating platform cruciate retaining endoprosthesis - A 6 year follow up.
http://www.lsis.com/channels/?query=45
BACKGROUND: Mobile-bearing Total Knee Replacement allows unconstrained axial rotation. Increased articular conformity minimizes polyethylene contact stresses, thereby reducing linear wear and fatigue failure. METHODS: We prospectively reviewed a consecutive series of 161 patients with mobile bearing total knee replacements using the PFC Sigma Cruciate Retaining Rotating Platform System. (DePuy, Leeds, United Kingdom) with midterm follow up (minimum 6 and maximum 9years, mean 7.2years). One (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study.
http://www.lsis.com/channels/?query=45
OBJECTIVES: To evaluate the performance of individual biomarkers and a multi-biomarker disease activity (MBDA) score in the early rheumatoid arthritis (RA) patient population from the computer assisted management in early rheumatoid arthritis (CAMERA) study.METHODS: Twenty biomarkers were measured in the CAMERA cohort, in which patients were treated with either intensive or conventional methotrexate-based treatment strategies. The MBDA score was calculated using the concentrations of 12 (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
14.05.2012 | NCBI PubMed: Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model.
http://www.lsis.com/channels/?query=45
The treatment of some inflammatory diseases, such as rheumatoid arthritis, remains an important target for studies because some patients are refractory to conventional treatment. Mycophenolate mofetil (MMF), an immunosuppressive drug, has been shown to have a beneficial effect on the therapy of inflammatory and autoimmune diseases. In the present study, we aimed to analyse the anti-inflammatory effect of MMF administered by oral route in the mouse carrageenan-induced air pouch model. Results: (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: T cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles.
http://www.lsis.com/channels/?query=45
ABSTRACT: INTRODUCTION: Anti-citrullinated peptide antibodies (ACPA) are found in rheumatoid arthritis (RA) patients with HLA-DR-chains encoding the shared epitope (SE) sequence. Citrullination can increase the immunogenicity of self-antigens, through increased binding affinity to SE-containing HLA-DR molecules. To characterize T cell autoreactivity towards citrullinated self-epitopes, we profiled responses of SE+ healthy controls and RA patients to citrullinated and unmodified epitopes of (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
16.05.2012 | NCBI PubMed: Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial.
http://www.lsis.com/channels/?query=45
Objective. To evaluate the safety and efficacy of 2-year administration of certolizumab pegol (CZP)?+?MTX in patients with active RA.Methods. Patients completing 52 weeks in the Rheumatoid Arthritis Prevention of Structural Damage (RAPID) 1 trial (52-week completers), or withdrawing at week 16 due to lack of ACR20 response were eligible for open-label treatment (CZP 400?mg every other week?+?MTX). After 2 years' treatment, HAQ-Disability Index response, ACR20/50/70 responses, DAS-28 (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Can Magnetic Resonance Imaging of the Hand and Wrist Differentiate Between Rheumatoid Arthritis and Psoriatic Arthritis in the Early Stages of the Disease?
http://www.lsis.com/channels/?query=45
OBJECTIVE: To investigate whether rheumatoid arthritis (RA) and psoriatic arthritis (PsA) can be differentiated in the early stages of the disease (duration of symptoms ?1 year) on the basis of magnetic resonance imaging (MRI) features of the hand and wrist. MATERIAL AND METHODS: Twenty early RA and 17 early PsA patients with symptomatic involvement of the wrist and hand joints and inconclusive radiographic studies were examined prospectively with contrast-enhanced MRI. Images were evaluated (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
16.05.2012 | NCBI PubMed: Dysexecutive Syndrome: A Specific Pattern of Cognitive Impairment in Systemic Sclerosis.
http://www.lsis.com/channels/?query=45
BACKGROUND AND PURPOSE: Systemic sclerosis (SSc) is a connective-tissue disorder characterized by microvascular damage and tissue fibrosis. Although overt nervous system involvement is unusual in SSc, imaging studies have shown cerebral hypoperfusion. We evaluated cognitive functions in patients with SSc who had no history of neurological involvement, to seek cognitive impairment caused by the suggested cerebral hypoperfusion. METHODS: We performed a comprehensive neuropsychological test (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
14.05.2012 | NCBI PubMed: Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.
http://www.lsis.com/channels/?query=45
OBJECTIVE: The study aimed determining whether assessment of COMP degradation products could serve as a serological disease course and therapeutic response predictor in arthritis. METHODS: We generated a panel of monoclonal antibodies against COMP fragments and developed a novel capture ELISA for detecting COMP fragments in patients with osteoarthritis (OA) and rheumatoid arthritis (RA). This test was also used to monitor COMP fragments in surgically induced OA, collagen induced arthritis (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.05.2012 | NCBI PubMed: Imaging rheumatic diseases.
http://www.lsis.com/channels/?query=45
Currently, more than 100 rheumatic diseases affect nearly 46 million Americans. Some of the most common rheumatic diseases include rheumatoid arthritis, osteoarthritis, lupus, psoriatic arthritis, ankylosing spondylitis, gout, and Sjögren syndrome. Rheumatic diseases are characterized by inflammation and lack of function in the joints and connective tissue. Early diagnosis and treatment of rheumatic disease is paramount in preventing damage and disability. Many radiologic modalities are used (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: Association between osteoporosis and urinary calculus: evidence from a population-based study.
http://www.lsis.com/channels/?query=45
This population-based case-control analysis investigated the association between osteoporosis and prior urinary calculus (UC) in Taiwan. We succeeded in detecting an association between osteoporosis and prior UC (adjusted odds ratio?=?1.66). This association was consistent and significant regardless of stone location. INTRODUCTION: UC has been demonstrated to be a risk factor for osteoporotic fractures, but no studies to date have directly investigated the association between UC and (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.
http://www.lsis.com/channels/?query=45
Mast cells are central players in immune surveillance and activation, positioned at the host-environment interface. Understanding the signaling events controlling mast cell function, especially those that maintain host homeostasis, is an important and still less understood area of mast cell-mediated disease. With respect to allergic disease, it is well established that IgE and its high affinity receptor Fc?RI are major mediators of mast cell activation. However, IgG-mediated signals can also (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
16.05.2012 | NCBI PubMed: CD23+CD21highCD1dhigh B Cells in Inflamed Lymph Nodes Are a Locally Differentiated Population with Increased Antigen Capture and Activation Potential.
http://www.lsis.com/channels/?query=45
CD23(+)CD21(high)CD1d(high) B cells in inflamed nodes (Bin cells) accumulate in the lymph nodes (LNs) draining inflamed joints of the TNF-?-transgenic mouse model of rheumatoid arthritis and are primarily involved in the significant histological and functional LN alterations that accompany disease exacerbation in this strain. In this study, we investigate the origin and function of Bin cells. We show that adoptively transferred GFP(+) sorted mature follicular B (FoB) cells home preferentially (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
16.05.2012 | NCBI PubMed: Identification of Imidazo-pyrrolopyridines as Novel and Potent JAK1 Inhibitors.
http://www.lsis.com/channels/?query=45
A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred binding conformation of clinically effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3. Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.01.2012 | NCBI PubMed: Satisfaction with access to health services: the perspective of estonian patients with rheumatoid arthritis.
http://www.lsis.com/channels/?query=45
In this cross-sectional study we explained the possible determinants of satisfaction with access to health services in patients with rheumatoid arthritis (RA). Of the 2000 randomly selected Estonian adult patients with RA, a total 1259 completed the survey. Regression analysis was used to analyse the predictors of patients' satisfaction with access to health services. Half of the respondents were satisfied with their access to health services. Factors that had a negative impact on satisfaction (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
16.05.2012 | NCBI PubMed: Molecular mechanisms of the inhibitory effects of bovine Lactoferrin on LPS-mediated osteoclastogenesis.
http://www.lsis.com/channels/?query=45
Lactoferrin (LF) is an important modulator of the immune response and inflammation. It has also been implicated in the regulation of bone tissue. In our previous study, we demonstrated that bovine LF (bLF) reduces LPS-induced bone resorption through a reduction of TNF-?production by osteoblasts. However, it was not known how bLF inhibits LPS-mediated TNF-? and RANKL production in osteoblasts. In the present study, we show that bLF impairs LPS-mediated TNF-? and RANKL (Receptor activator of (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
14.05.2012 | NCBI PubMed: Cardiovascular Risk and Psoriasis: the Role of Biologic Therapy.
http://www.lsis.com/channels/?query=45
One of the most clinically important aspects of recent advances in our understanding of psoriasis has been the detection of an association between this disease and an increased prevalence of cardiovascular risk factors. This increase in prevalence is, in turn, linked to a greater risk of morbidity and mortality related to acute myocardial infarction, cerebrovascular accident, and peripheral arterial disease. The chronic systemic inflammation present in psoriasis could explain why moderate to (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: Quercetin Inhibits IL-1?-Induced Proliferation and Production of MMPs, COX-2, and PGE2 by Rheumatoid Synovial Fibroblast.
http://www.lsis.com/channels/?query=45
This study was aimed to determine the effects of quercetin on the interleukin-1? (IL-1?)-induced proliferation of rheumatoid synovial fibroblasts (RASFs) and production of matrix metalloproteinases (MMPs), cyclooxygenase (COX), and prostaglandin E2 (PGE2) by RASFs. The proliferation and apoptosis of RASFs was evaluated with CCK-8 reagent and flow cytometry in the presence of IL-1with CCK-8 reagquercetin. The expression of MMPs, IL-1? enhanced the expression of MMP-1, MMP-3, tissue inhibitor (…)
-
text/html
http://www.sciencedaily.com
ScienceDaily
15.05.2012 | ScienceDaily: New Biomarker Test Predicts Arthritis Before Symptoms Appear
http://www.lsis.com/channels/?query=45
ScienceDaily (May 15, 2012) More than 27 million adults currently suffer from osteoarthritis, which is the most common form of arthritis. In the past, doctors have been unable to diagnose patients with arthritis until they begin to show symptoms, which include joint pain and stiffness. By the time these symptoms are present, it is often too late for preventive and minimally invasive treatment options to be effective. Now, a research team from the University of Missouri's Comparative (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CT.
http://www.lsis.com/channels/?query=45
OBJECTIVES: To determine the accuracy of ultrasonography (US) for bone erosion detection in different areas of rheumatoid arthritis (RA) metacarpophalangeal (MCP) joints with multislice CT as the reference method. Second, to establish the necessary bone volume loss on CT for US to reliably detect it as an erosion, and finally to compare two semiquantitative US-erosion scoring methods.METHODS: The 2nd-5th MCP joints of 49 patients with RA were examined by CT and US, and evaluated for the (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
08.05.2012 | NCBI PubMed: Detection of Antibodies against Synthetic Peptides Mimicking Ureases Fragments in Sera of Rheumatoid Arthritis Patients.
http://www.lsis.com/channels/?query=45
Rheumatoid arthritis (RA) is a chronic disease with an autoimmunological background. RA is mostly characterized by systemic inflammation and injuries of synovial joints. There is a hypothesis that bacterial infections may be connected with development of the disease. It has been suggested that molecular mimicry between bacterial and human antigens may be one of possible mechanisms of RA development. One of potential antigens involved in this mechanism is urease - enzyme with high structural (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.04.2008 | NCBI PubMed: The prevalence of bronchopulmonary infection among patients with rheumatoid arthritis versus non rheumatoid arthritis patients.
http://www.lsis.com/channels/?query=45
A high frequency of bronchopulmonary infections complicating rheumatoid arthritis has been described in reports of case series. This study was undertaken to confirm and compare these finding in patients with RA and control. 117 patients with RA and 103 patients with OA/soft tissue rheumatism as controls. Study subjects were studied using their medical records available from hospitals' casenotes and GP data base. Details of all documented bronchopulmonary infections for the preceding year (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.05.2012 | NCBI PubMed: Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia.
http://www.lsis.com/channels/?query=45
To estimate the prevalence of low serum vitamin D level (25[OH]D) in patients with rheumatoid arthritis (RA) compared with healthy controls, and to analyze the association between 25(OH)D and disease activity. |-| Saudi Med J. |-| Attar SM. |-| Department of Internal Medicine, King Abdulaziz University Hospital, PO Box 80215, Jeddah 21589, Kingdom of Saudi Arabia. Fax. +966 (2) 6408315. E-mail: suzan_attar@hotmail.com.
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Treatment with Biologic Agents Improves the Prognosis of Patients with Rheumatoid Arthritis and Amyloidosis.
http://www.lsis.com/channels/?query=45
OBJECTIVE: Reactive amyloid A (AA) amyloidosis is a serious and life-threatening systemic complication of rheumatoid arthritis (RA). We evaluated the safety of therapy with anti-tumor necrosis factor and antiinterleukin 6 biologic agents in RA patients with reactive AA amyloidosis, together with prognosis and hemodialysis (HD)-free survival, in comparison with patients with AA amyloidosis without such therapy. METHODS: One hundred thirty-three patients with an established diagnosis of reactive (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial.
http://www.lsis.com/channels/?query=45
OBJECTIVES: CCX354-C is a specific, orally administered antagonist of the C-C chemokine receptor 1, which regulates migration of monocytes and macrophages to synovial tissue. This clinical trial evaluated the safety and efficacy of CCX354-C in patients with rheumatoid arthritis (RA).METHODS: CARAT-2 is a 12-week double-blind, randomised, placebo controlled trial in 160 patients with RA, with 68 tender joint count and 66 swollen joint count ?8 and C-reactive protein (CRP) 5 mg/l, despite (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
16.05.2012 | NCBI PubMed: Role of scintigraphy with (99m)Tc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis.
http://www.lsis.com/channels/?query=45
PURPOSE: The rationale for the present study was to evaluate the predictive role of (99m)Tc-infliximab scintigraphy in therapy decision-making in patients with refractory monoarthritis and also candidates for intraarticular (IA) infliximab treatment. METHODS: We studied 12 patients (5 with rheumatoid arthritis and 7 with spondyloarthropathy) with active monoarthritis (11 knees and 1 ankle) that had lasted for at least 3 months. Patients were evaluated clinically and ultrasonographically at (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Autofeedback from Ultrasound Images Provides Rapid Improvement in Palpation Skills for Identifying Joint Swelling in Rheumatoid Arthritis.
http://www.lsis.com/channels/?query=45
OBJECTIVE: Joint swelling, an important factor in the classification criteria and disease activity assessment in rheumatoid arthritis (RA), renders joint palpation a necessary skill for physicians. Ultrasound (US) examination that visualizes soft tissue abnormalities is now used to assess musculoskeletal disease. We assessed the usefulness of US assessments in enhancing physical joint examination skills. METHODS: We examined 1944 joints (bilateral shoulder, elbow, wrist, metacarpophalangeal (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Evaluation of a Shared Autoimmune Disease-associated Polymorphism of TRAF6 in Systemic Sclerosis and Giant Cell Arteritis.
http://www.lsis.com/channels/?query=45
OBJECTIVE: We evaluated whether a single-nucleotide polymorphism (SNP) of the TRAF6 gene previously associated with systemic lupus erythematosus and rheumatoid arthritis may be a common risk factor for systemic sclerosis (SSc) and giant cell arteritis (GCA). METHODS: A total of 1185 patients with SSc, 479 patients with biopsy-proven GCA, and 1442 unrelated healthy controls of white Spanish origin were genotyped for the rs540386 variant using a specifically designed TaqMan© allele (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Increased Serum Interleukin 22 in Patients with Rheumatoid Arthritis and Correlation with Disease Activity.
http://www.lsis.com/channels/?query=45
OBJECTIVE: To analyze the role of interleukin 22 (IL-22) in rheumatoid arthritis (RA). METHODS: IL-22 serum levels were measured in 83 patients with established RA under treatment with disease-modifying antirheumatic drugs and in 30 healthy controls matched for age and sex. Patients were assessed for clinical and laboratory variables. Correlations of IL-22 serum levels with disease activity measures [Clinical Disease Activity Index (CDAI) and Disease Activity Score for 28 joints (DAS28)], (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial.
http://www.lsis.com/channels/?query=45
OBJECTIVE: To determine the relationship between timing and magnitude of Disease Activity Score [DAS28(ESR)] nonresponse (DAS28 improvement thresholds not reached) during the first 12 weeks of treatment with certolizumab pegol (CZP) plus methotrexate, and the likelihood of achieving low disease activity (LDA) at 1 year in patients with rheumatoid arthritis. METHODS: In a post-hoc analysis of the RAPID 1 study, patients achieving LDA [DAS28(ESR) ? 3.2] at Year 1 were assessed according to (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab.
http://www.lsis.com/channels/?query=45
OBJECTIVE: An atherogenic lipid profile is an established risk factor for cardiovascular (CV) diseases. Interestingly, high inflammatory states as present in rheumatoid arthritis (RA) are associated with unfavourable lipid profile. Data about effects of novel immunomodulating agents as rituximab (RTX) on lipid profile are limited. Therefore, changes in lipids in RTX treated RA patients were evaluated.METHODS: In 49 consecutive RTX treated RA patients, serum and EDTA plasma samples were (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
17.05.2012 | NCBI PubMed: Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.
http://www.lsis.com/channels/?query=45
OBJECTIVE: The associations between elevated levels of serum Krebs von den Lungen-6 (KL-6) and treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF) inhibitors were investigated in five Japanese clinical trials. METHODS: Percentages and incidence rates were calculated for elevated serum KL-6 levels. Adverse events associated with elevated levels of serum KL-6 were investigated. RESULTS: In RISING, a clinical trial for infliximab, 15.6 % of the enrolled patients met criterion (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Validity and Reliability Problems with Patient Global as a Component of the ACR/EULAR Remission Criteria as Used in Clinical Practice.
http://www.lsis.com/channels/?query=45
OBJECTIVE: To investigate what factors influence patient global health assessment (PtGlobal), and how those factors and the reliability of PtGlobal affect the rate, reliability, and validity of recently published American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) remission criteria when used in clinical practice. METHODS: We examined consecutive patients with RA in clinical practice and identified 77 who met ACR/EULAR joint criteria for (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
15.05.2012 | NCBI PubMed: Carotid Atherosclerosis, Disease Measures, Oxidized Low-density Lipoproteins, and Atheroprotective Natural Antibodies for Cardiovascular Disease in Early Rheumatoid Arthritis - An Inception Cohort Study.
http://www.lsis.com/channels/?query=45
OBJECTIVE: Although an enhanced risk of cardiovascular disease (CVD) in persons with rheumatoid arthritis (RA) is well established, the mechanisms behind it remain unclear. We studied whether carotid atherosclerosis, RA disease measures, or potential cardiovascular biomarkers influenced the incidence of CVD in an RA inception cohort. METHODS: RA disease measures and CVD biomarkers were assessed at 0, 3, 12, 24, and 60 months after disease onset, and carotid ultrasonography after 5 years. The (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
14.05.2012 | NCBI PubMed: Newly Reported Lupus and Rheumatoid Arthritis in Relation to Deployment Within Proximity to a Documented Open-Air Burn Pit in Iraq.
http://www.lsis.com/channels/?query=45
OBJECTIVE: To assess the relationship between possible exposure to smoke from documented open-air burn pits and newly reported lupus and rheumatoid arthritis among Millennium Cohort participants who have deployed in support of operations in Iraq and Afghanistan. METHODS: Prospectively assessed self-reported lupus and rheumatoid arthritis among deployers who completed both 2004-2006 and 2007-2008 questionnaires. RESULTS: After exclusions, more than 18,000 participants were deployed, (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
01.05.2012 | NCBI PubMed: Minocycline-induced Black Bone Disease Encountered During Total Knee Arthroplasty.
http://www.lsis.com/channels/?query=45
Finding discolored bone intraoperatively can be confusing and concerning to orthopedic surgeons. Multiple causes of pigmented bone exist, including ochronosis, metabolic bone diseases, metal deposits, sequestrum, metastatic disease, and minocycline use. Bone quality is an important consideration in intraoperative decision making with respect to components and fixation options in total joint arthroplasty. Abnormal bone encountered in routine arthroplasty can raise concerns over the integrity (…)
-
text/html
http://www.biospace.com
BioSpace
17.05.2012 | BioSpace: GBI Research Release: Novel Drugs to Drive Arthritis Market
http://www.lsis.com/channels/?query=45
NEW YORK (GBI Research), 17 May 2012 - The fast-growing therapeutics market for arthritis is expected to grow further in the coming years as many new companies rush to cater for rising incidence rates, according to a new report by pharmaceutical experts GBI Research. The new report* examines how arthritis therapeutics are becoming a gigantic attraction in the global pharmaceutical industry as the condition is increasingly considered to be one of the most common causes of disabilities. The (…)
-
text/html
http://www.biospace.com
BioSpace
17.05.2012 | BioSpace: MorphoSys AG to Present MOR208 Preclinical Combination Therapy Data at American Society of Clinical Oncology Meeting
http://www.lsis.com/channels/?query=45
MARTINSRIED, GERMANY and MUNCHEN, GERMANY-(Marketwire - May 17, 2012) - MorphoSys AG / MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Synergistic Effects Seen with Four Approved Treatment Options Including Rituximab and Ofatumumab MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced promising pre-clinical data on its (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
12.05.2012 | NCBI PubMed: Total shoulder arthroplasty - Arthroplasty for glenohumeral arthropathies: Results and complications after a minimum follow-up of 8years according to the type of arthroplasty and etiology.
http://www.lsis.com/channels/?query=45
INTRODUCTION: Arthroplasty for glenohumeral arthropathies have specific complications and the final results are sometimes more dependent upon the type of shoulder arthroplasty than the initial etiology. The aim of our study was to evaluate the rate of complications and the functional improvement with different types of shoulder arthroplasties after a minimum follow-up of 8years. MATERIALS AND METHODS: This was a multicenter retrospective study of 198 shoulders including 85 primary (…)
-
text/html
http://www.ncbi.nlm.nih.gov
NCBI PubMed
22.03.2012 | NCBI PubMed: Rheumatoid arthritis: role of the nurse and multidisciplinary team.
http://www.lsis.com/channels/?query=45
Rheumatoid arthritis is a complex chronic inflammatory condition which has both musculoskeletal and extra-articular effects. It is the most common inflammatory arthropathy, and has the potential to cause a significant impact on quality of life. The predominant features of the disease are inflammation, pain, reduced levels of function and increased morbidity. Despite the number of treatments available to suppress the effects of rheumatoid arthritis, it is not always possible to establish good (…)